Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Process Development
Analytical Methods Support
Peptides
NCEs
Innovation Management
Generic Peptides
Agricultural peptides
GMP Peptides
Custom Peptide Synthesis
GMP Peptide Manufacturing
NCE peptides
Peptide Active Pharmaceutical Ingredients (APIs)
Regulatory Support
Biochemicals
Preclinical Manufacturing
Manufacturing
Commercial Peptide Manufacturing
Peptide Contract Development & Manufacturing Organization (CDMO)
Clinical Peptides
Cosmetic Peptides
Date founded
2005
Funding rounds raised
Total raised
$24M
from 2 investors over 2 rounds
A
AmbioPharm - A Global Peptide CDMO raised undisclosed on September 10, 2018
Investors: The Carlyle Group
A
AmbioPharm - A Global Peptide CDMO raised $24M on November 19, 2014
Investors: MVM Partners